Merit Medical Systems Gross Profit 2012-2026 | MMSI

Merit Medical Systems gross profit from 2012 to 2026. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Merit Medical Systems Annual Gross Profit
(Millions of US $)
2025 $738
2024 $643
2023 $584
2022 $519
2021 $485
2020 $401
2019 $432
2018 $395
2017 $326
2016 $265
2015 $236
2014 $225
2013 $194
2012 $182
2011 $165
Merit Medical Systems Quarterly Gross Profit
(Millions of US $)
2026-03-31 $185
2025-12-31 $195
2025-09-30 $186
2025-06-30 $184
2025-03-31 $172
2024-12-31 $173
2024-09-30 $158
2024-06-30 $161
2024-03-31 $152
2023-12-31 $151
2023-09-30 $142
2023-06-30 $153
2023-03-31 $138
2022-12-31 $135
2022-09-30 $129
2022-06-30 $135
2022-03-31 $121
2021-12-31 $129
2021-09-30 $120
2021-06-30 $124
2021-03-31 $112
2020-12-31 $111
2020-09-30 $102
2020-06-30 $84
2020-03-31 $104
2019-12-31 $112
2019-09-30 $104
2019-06-30 $112
2019-03-31 $105
2018-12-31 $105
2018-09-30 $102
2018-06-30 $100
2018-03-31 $88
2017-12-31 $86
2017-09-30 $81
2017-06-30 $84
2017-03-31 $76
2016-12-31 $70
2016-09-30 $68
2016-06-30 $67
2016-03-31 $60
2015-12-31 $60
2015-09-30 $59
2015-06-30 $61
2015-03-31 $55
2014-12-31 $60
2014-09-30 $57
2014-06-30 $56
2014-03-31 $52
2013-12-31 $53
2013-09-30 $51
2013-06-30 $47
2013-03-31 $43
2012-12-31 $45
2012-09-30 $45
2012-06-30 $47
2012-03-31 $44
2011-12-31 $42
2011-09-30 $41
2011-06-30 $42
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $4.072B $1.516B
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $106.025B 23.03
Cardinal Health (CAH) United States $50.715B 22.43
Becton Dickinson (BDX) United States $43.913B 11.10
West Pharmaceutical Services (WST) United States $18.493B 35.19
Straumann Holding AG (SAUHY) Switzerland $16.902B 0.00
Cooper (COO) United States $13.894B 16.52
Align Technology (ALGN) United States $12.400B 21.09
Henry Schein (HSIC) United States $8.645B 15.16
DENTSPLY SIRONA (XRAY) United States $2.339B 7.36
STAAR Surgical (STAA) United States $1.309B 0.00
CONMED (CNMD) United States $1.107B 7.97
Pro-Dex (PDEX) United States $0.165B 19.65
Lifevantage (LFVN) United States $0.053B 5.46
Axe Compute (AGPU) United States $0.022B 0.00